vialaudit
The Roundup
ss-31 · iowa

Is SS-31 legal in Iowa?

status · caveats apply
FDA-approved as Forzinity (NDA 215244, Sep 2025) for Barth syndrome; 'SS-31 research peptide' from retail vendors is diversion of an approved drug. No state-level peptide restrictions beyond federal law in Iowa.

category: approved drug diversion · last verified May 13, 2026

§ 01

Quick answer

FDA-approved as Forzinity (NDA 215244, Sep 2025) for Barth syndrome; 'SS-31 research peptide' from retail vendors is diversion of an approved drug. No state-level peptide restrictions beyond federal law in Iowa.
§ 02

Full status breakdown

Federal status

FDA approval
approved as drug · brand: Forzinity · NDA 215244 · approved Sep 19, 2025
Indications: improve muscle strength in adult and pediatric patients (≥30 kg) with Barth syndrome
DEA scheduling
not scheduled
503A compounding
Bulks list: not on list
Do-not-compound list: not on list
Not eligible (approved drug). 503A 'essentially a copy' rule applies for any 'SS-31' compounded version.
FDA Warning Letters
none on record for this compound
Shortage status
not currently on shortage list
Sale framing
Research-use-only posture: CRITICAL CROSS-REFERENCE: SS-31 = elamipretide = Bendavia = Forzinity. All four names refer to the same molecule. Any 'SS-31 research peptide' sold by a research-chemical vendor is diversion of Forzinity, an approved drug.
Personal possession: Not federally criminalized.

Iowa — state-specific

Sport-body status

WADA 2026
not on prohibited list
Not explicitly named.
USADA
unknown
NCAA
unknown

What we couldn’t verify

§ 03

Also known as

SS-31 is also marketed or referenced under the following names (vendor pseudonyms, brand names, chemical identifiers):

  • Elamipretide
  • Forzinity
  • Bendavia
  • MTP-131
  • NDA 215244
  • Stealth BioTherapeutics SS-31
§ 04

Disclaimer

§ 05

Related

the roundup · monthly

Receipts in your inbox. Once a month.

New audits, expired coupons pruned, lab notes from vials still on the bench. No marketing. No lifestyle copy. Unsubscribe in one click.

14,200 subscribers· 0 sponsored items· 11 issues since launch